FDA recall, , Low risk
The Blood Connection Apheresis Platelets, Leukocytes Reduced
Apheresis Platelets, Leukocytes Reduced were exposed to unacceptable storage temperatures.
Recall ended Aug 7, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The Blood Connection, Inc. recalled Apheresis Platelets, Leukocytes Reduced because the product was exposed to unacceptable storage temperatures. The recall began June 19, 2025, and was added to the FDA's Enforcement Report on August 7, 2026. The affected product was distributed in North Carolina.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, Leukocytes Reduced
Recall details
- Company began the recall
- Sold in
- Company
- Blood Connection, Inc. (The)
- Hazard
- Processing problem
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99272
- Recall number
- B-0128-2026
All recalls from Blood Connection, Inc. (The)
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
